Combining chemotherapy and targeted therapies in metastatic colorectal cancer

@inproceedings{Garc2007CombiningCA,
  title={Combining chemotherapy and targeted therapies in metastatic colorectal cancer},
  author={J. J. Garc},
  year={2007}
}
Colorectal cancer remains one of the major causes of cancer death worldwide. During the past years, the development of new effective treatment options has led to a considerable improvement in the outcome of this disease. The advent of agents such as capecitabine, irinotecan, oxaliplatin, cetuximab and bevacizumab has translated into median survival times in the range of 2 years. Intense efforts have focused on identifying novel agents targeting specific growth factor receptors, critical signal… CONTINUE READING

Topics from this paper.

Similar Papers